DIN 02026961 — KAYEXALATE 1 G
KAYEXALATE is a powder for suspension of Sodium Polystyrene Sulfonate marketed by SANOFI-AVENTIS CANADA INC. The full Sodium Polystyrene Sulfonate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02026961
- Brand name
- KAYEXALATE
- Active ingredient
- Sodium Polystyrene Sulfonate
- Strength
- 1 G
- Dosage form
- POWDER FOR SUSPENSION
- Route
- ORAL; RECTAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Potassium-binding cation-exchange resin
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sodium Polystyrene Sulfonate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02497557 | JAMP SODIUM POLYSTYRENE SULFONATE | 1 G | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | MARKETED |
| 02473941 | ODAN-SODIUM POLYSTYRENE SULFONATE | 1 G | POWDER FOR SUSPENSION | ODAN LABORATORIESLTD | MARKETED |
| 02473968 | ODAN-SODIUM POLYSTYRENE SULFONATE | 250 MG | SUSPENSION | ODAN LABORATORIESLTD | MARKETED |
| 00755338 | SOLYSTAT | 1 G | POWDER FOR SUSPENSION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 00769541 | SOLYSTAT | 250 MG | SUSPENSION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |